Kurse um 15 Minuten verzögert
Die Reihe ist auf die aktuelle Aktienzahl nach Splits umgerechnet; Dividenden sind nicht im Kurs enthalten
| Datum | Eröffnung | Hoch | Tief | Schluss | Volumen, Stück |
|---|---|---|---|---|---|
| 15. September 2026 | 265,81 | 267,20 | 260,68 | 267,20 | 5 Mio. |
| 14. September 2026 | 271,00 | 271,55 | 266,19 | 266,32 | 5 Mio. |
| 11. September 2026 | 268,03 | 270,40 | 265,25 | 265,58 | 5 Mio. |
| 10. September 2026 | 270,21 | 271,27 |
Auf Basis der Berichte bis 31. Dezember 2025
After spinning off its consumer arm, Johnson & Johnson is a pharmaceuticals and medical-technology company.
The pharmaceutical half concentrates on oncology, immunology, neuroscience and infectious disease. As with any drug maker, its fortunes follow the patent cycle: key medicines carry the profit until protection lapses, and the pipeline must have a replacement ready.
The other half is medical technology: surgical equipment, orthopaedic implants, cardiology and vision devices. That business is less explosive than pharmaceuticals but also less exposed to patent cliffs — it tracks procedure volumes and hospital budgets.
A separate and long-running factor is litigation, above all the talc claims. Their resolution stretches over years and creates uncertainty in valuing the liabilities. Johnson & Johnson has raised its dividend for decades and belongs to the group of stocks bought for durability rather than pace.
Adresse:ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933, US
| 992 Mio. |
| ABTAbbott Laboratories | 102,38 | +1,50 % | 848 Mio. |
| VRTXVertex Pharmaceuticals Incorporated | 513,25 | −0,20 % | 582 Mio. |
| BMYBristol-Myers Squibb Company | 63,15 | −0,71 % | 575 Mio. |
| AZNAstraZeneca PLC | 165,60 | +1,66 % | 573 Mio. |
| 265,72 |
| 266,35 |
| 5 Mio. |
| 09. September 2026 | 268,51 | 270,10 | 266,73 | 267,08 | 6 Mio. |
| 08. September 2026 | 271,28 | 271,99 | 266,88 | 269,12 | 8 Mio. |
| 04. September 2026 | 275,13 | 277,80 | 274,75 | 275,23 | 4 Mio. |
| 03. September 2026 | 277,32 | 278,89 | 273,16 | 278,43 | 6 Mio. |
| 02. September 2026 | 274,74 | 281,07 | 273,53 | 275,21 | 8 Mio. |
| 01. September 2026 | 270,83 | 271,91 | 267,02 | 271,19 | 6 Mio. |
| 31. August 2026 | 267,13 | 267,77 | 265,17 | 265,85 | 8 Mio. |
| 28. August 2026 | 265,78 | 268,38 | 264,27 | 268,04 | 6 Mio. |
| 27. August 2026 | 268,45 | 268,45 | 263,83 | 265,77 | 7 Mio. |
| 26. August 2026 | 271,97 | 272,91 | 269,55 | 270,00 | 7 Mio. |
| 25. August 2026 | 271,00 | 273,80 | 270,18 | 273,14 | 5 Mio. |
| 24. August 2026 | 269,74 | 273,98 | 268,57 | 273,04 | 5 Mio. |
| 21. August 2026 | 267,83 | 272,66 | 267,00 | 270,24 | 6 Mio. |
| 20. August 2026 | 273,40 | 273,40 | 267,37 | 267,37 | 6 Mio. |
| 19. August 2026 | 273,00 | 276,47 | 270,56 | 273,41 | 8 Mio. |
| 18. August 2026 | 267,67 | 271,73 | 266,33 | 271,11 | 8 Mio. |